These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 28252887)
1. Pharmaceuticals and Medical Devices: FDA Oversight. White RS; Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-74. PubMed ID: 28252887 [No Abstract] [Full Text] [Related]
2. Pharmaceutical and Medical Devices: FDA Oversight. White RS; Issue Brief Health Policy Track Serv; 2015 Dec; ():1-97. PubMed ID: 27116797 [No Abstract] [Full Text] [Related]
3. Pharmaceuticals and Medical Devices: FDA Oversight. White RS; Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-44. PubMed ID: 30695852 [No Abstract] [Full Text] [Related]
4. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914 [No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: FDA oversight. Berry MD Issue Brief Health Policy Track Serv; 2013 Dec; ():1-123. PubMed ID: 24482893 [No Abstract] [Full Text] [Related]
6. Pharmaceuticals and Medical Devices: FDA Oversight. White RS; Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-43. PubMed ID: 29361661 [No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: FDA oversight. Issue brief. Berry MD Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449 [No Abstract] [Full Text] [Related]
8. Drug marketing exclusivity under United States and European Union law. Junod V Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347 [No Abstract] [Full Text] [Related]
9. Pharmaceuticals and medical devices: business practices. Steiner DJ Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889 [No Abstract] [Full Text] [Related]
10. Pharmaceuticals and medical devices: FDA oversight. Issue brief. Thomson Reuters/West Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: FDA oversight. ; Berry MD; White RS Issue Brief Health Policy Track Serv; 2014 Dec; ():1-96. PubMed ID: 25775703 [No Abstract] [Full Text] [Related]
12. Injecting Safety into Supplements - Modernizing the Dietary Supplement Law. Cohen PA; Bass S N Engl J Med; 2019 Dec; 381(25):2387-2389. PubMed ID: 31851798 [No Abstract] [Full Text] [Related]
13. Pharmaceuticals and medical devices: FDA oversight. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718 [No Abstract] [Full Text] [Related]
14. Over-the-counter sales of statins and other drugs for asymptomatic conditions. Tinetti ME N Engl J Med; 2008 Jun; 358(25):2728-32. PubMed ID: 18565867 [No Abstract] [Full Text] [Related]
15. Federal pre-emption under the Food, Drug & Cosmetic Act from Medtronic, Inc. v. Lohr; Pliva. Inc. v. Mensing. Ball FR Health Care Law Mon; 2011 Sep; 2011(9):2-8. PubMed ID: 21949984 [No Abstract] [Full Text] [Related]
16. The federal preemption debate in pharmaceutical labeling product liability actions. Gross JM; Curry JA Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866 [No Abstract] [Full Text] [Related]
18. What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help. Waxman H; Corr B; Martin K; Duong S Issue Brief (Commonw Fund); 2018 Apr; 2018():1-10. PubMed ID: 29992802 [TBL] [Abstract][Full Text] [Related]
19. Abuses of FDA Regulatory Procedures - The Case of Suboxone. Haffajee RL; Frank RG N Engl J Med; 2020 Feb; 382(6):496-498. PubMed ID: 31914238 [No Abstract] [Full Text] [Related]
20. Pharmaceuticals and Medical Devices: FDA Oversight. Berry MD; White RS; Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-59. PubMed ID: 28252888 [No Abstract] [Full Text] [Related] [Next] [New Search]